Results 121 to 130 of about 883,208 (316)

Analysis of Inhibitory Effect of the Double-layer Nano-infusion on Vascular Restenosis in Animal Models of Coronary Atherosclerosis

, 2022
Ge Cao, Hui Kang, Hui Yu, Qing He
openalex   +2 more sources

Effects of mycophenolate mofetil on key pattern of coronary restenosis: a cascade of in vitro and ex vivo models

BMC Cardiovascular Disorders, 2005
BackgroundMycophenolate mofetil (MMF), the prodrug of mycophenolic acid (MPA), is a rationally designed immunosuppressive drug. The current study investigates the effect of MMF on key pattern of restenosis in a cascade of in vitro and ex vivo models ...
R. Voisard, Sandra Viola, Verena Kaspar, Christian M Weber, Lutz von Müller, R. Baur, I. Gastrock-Balitsch, Vinzenz Hombach   +7 more
semanticscholar   +1 more source

Percutaneous Management of Right Ventricular Outflow Tract Obstruction in an Adult Patient After Atrial Switch: A Case for Targeted Infundibular Ablation

Catheterization and Cardiovascular Interventions, Volume 107, Issue 1, Page 357-360, January 1, 2026.
ABSTRACT Alcohol septal ablation is a well‐established treatment method for patients with hypertrophic cardiomyopathy. We present a case report of a patient with transposition of the great arteries (TGA) after a Mustard procedure, who developed significant right ventricular outflow tract obstruction (RVOTO), functionally resembling subaortic stenosis ...
Vera Osberghaus, Kerstin Wustmann, Pinar Bambul Heck, Stanimir Georgiev, Andreas Eicken, Peter Ewert, Katarzyna Gendera   +6 more
wiley   +1 more source

Preclinical Evaluation of a Novel Polymer-free Everolimus-eluting Stent in a Mid-term Porcine Coronary Restenosis Model. [PDF]

J Korean Med Sci, 2021
Cho KH, Jeong MH, Park DS, Kim M, Kim J, Park JK, Han X, Hyun DY, Kim MC, Sim DS, Hong YJ, Kim JH, Ahn Y.   +12 more
europepmc   +1 more source

PRECLINICAL EVALUATION OF THE VASCULAR EFFECTS OF REJUVENATE® COBALT CHROMIUM CORONARY STENT SYSTEM IMPLANTED IN THE PORCINE CORONARY IN STENT RESTENOSIS MODEL

, 2021
Murtaza Najabat Ali, Mariam Mir, Piotr Buszman   +2 more
openalex   +2 more sources

ASSOCIATION OF HIGH LIPOPROTEIN(a) LEVELS WITH CORONARY ARTERY PATENCY DURING THE FIRST YEAR AFTER PERCUTANEOUS CORONARY INTERVENTIONS

Klinicist, 2014
Objective: to study an association of high lipoprotein(a) [Lp(a)] levels with the development of restenosis and the progression of coronaryatherosclerosis after percutaneous coronary interventions (PCI) in patients with chronic coronary heart disease ...
M. V. Ezhov, M. S. Safarova, Yu. G. Matchin, D. I. Soboleva, O. I. Afanasyeva, S. N. Pokrovsky   +5 more
doaj   +1 more source

Predictive value of inflammatory factors on coronary restenosis after percutaneous coronary intervention in patients with coronary heart disease: A protocol for systematic review and meta-analysis. [PDF]

Medicine (Baltimore), 2021
Chu X, Wang R, Song G, Jiang X.
europepmc   +1 more source

Dual control of vascular tone and remodelling by ATP released from nerves and endothelial cells [PDF]

, 2008
Purinergic signalling is important both in short-term control of vascular tone and in longer-term control of cell proliferation, migration and death involved in vascular remodelling.
Burnstock, G
core  

Results of Coronary Stenting for Restenosis

Journal of the American College of Cardiology, 1996
This study attempted to analyze immediate and long-term angiographic and clinical results of coronary stent implantation for restenosis in a consecutive group of patients.The rate of stent utilization in patients with coronary artery disease has increased exponentially in recent years.
COLOMBO, ANTONIO, FERRARO, MASSIMO, ITOH, AKIRA, MARTINI, GIOVANNI, BLENGINO, SIMONETTA, FINCI, LEO   +5 more
openaire   +2 more sources

Rationale and Design of the PASSIVATE‐CAP Trial: The Preventive Intervention Value of Drug‐Coated Balloons in Vulnerable Coronary Atherosclerotic Plaques

Clinical Cardiology, Volume 49, Issue 1, January 2026.
PASSIVATE‐CAP Research Overview and Flowchart. ABSTRACT Background Patients with acute coronary syndrome (ACS) face a significantly increased risk of cardiovascular events due to vulnerable plaques. However, no clear evidence supports performing preventive percutaneous coronary intervention (PCI) for non‐flow‐limiting vulnerable plaques.
Zhongxiu Chen, Junyan Zhang, Minggang Zhou, Shichu Liang, Yong Chen, Chen Li, Hua Wang, Jiafu Wei, Baotao Huang, Mian Wang, Yong He, for the PASSIVATE‐CAP trial investigator   +11 more
wiley   +1 more source